The objective of this study was to characterize a novel subset of CNH endometrial cancer, MECOM amplified, and to examine the overlap of MECOM amplification with amplification in CCNE1 and ERBB2 using a publicly available dataset. Here, CCNE1 is linked to endometrial cancer.